| mTOR-mediated regulation of immune responses in cancer and tumor microenvironment S Mafi, B Mansoori, S Taeb, H Sadeghi, R Abbasi, WC Cho, ... Frontiers in immunology 12, 774103, 2022 | 92 | 2022 |
| PI3K/Akt/mTOR pathway: a potential target for anti-SARS-CoV-2 therapy S Fattahi, Z Khalifehzadeh-Esfahani, M Mohammad-Rezaei, S Mafi, ... Immunologic research 70 (3), 269-275, 2022 | 56 | 2022 |
| Mutant P53 in the formation and progression of the tumor microenvironment: friend or foe ER Asl, D Rostamzadeh, PHG Duijf, S Mafi, B Mansoori, S Barati, WC Cho, ... Life sciences 315, 121361, 2023 | 19 | 2023 |
| The mTOR signaling pathway interacts with the ER stress response and the unfolded protein response in cancer S Mafi, E Ahmadi, E Meehan, C Chiari, B Mansoori, H Sadeghi, S Milani, ... Cancer Research 83 (15), 2450-2460, 2023 | 7 | 2023 |
| Update on mesenchymal stem cells: a crucial player in cancer immunotherapy S Taeb, D Rostamzadeh, S Mafi, M Mofatteh, A Zarrabi, K Hushmandi, ... Current Molecular Medicine 24 (1), 98-113, 2024 | 5 | 2024 |
| mTOR-mediated regulation of immune responses in cancer and tumor microenvironment. Front Immunol 12: 774103 S Mafi, B Mansoori, S Taeb, H Sadeghi, R Abbasi, WC Cho, ... | 5 | 2021 |
| Targeting PERK and GRP78 in Colorectal Cancer: Genetic Insights and Novel Therapeutic Approaches S Mafi, M Dehghani, B Khalvati, H Abidi, M Ghorbani, P Jalali, R Whichelo, ... European Journal of Pharmacology, 176899, 2024 | | 2024 |
| Reprogramming the Cellular, Molecular and Metabolic Architecture of the Tumor Microenvironment for Effective Cancer Immunotherapy S Chakraborty, D Han, D Kumar, A Shanker Frontiers Media SA, 2023 | | 2023 |
Davoud RostamzadehUniversity of Connecticut Health Center, Department of Immunology在 uchc.edu 的电子邮件经过验证
Davoud RostamzadehUniversity of Connecticut Health Center, Department of Immunology在 uchc.edu 的电子邮件经过验证
Behzad MansooriThe Wistar Institute, Cellular and molecular oncogenesis Program, Philadelphia, PA, USA在 wistar.org 的电子邮件经过验证